SynopsisMeasles and Rubella Vaccine is a live virus vaccine used to vaccinate against measles and rubella. Global Measles and Rubella Vaccine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the per.....
SynopsisREVLIMID® (lenalidomide), an immunomodulatory therapy used to treat people with multiple myeloma The global Revlimid market was valued at US$ 10350 million in 2023 and is anticipated to reach US$ 6006.3 million by 2030, witnessing a CAGR of -5.2% during .....
SynopsisTherapeutic recombinant proteins are proteins that are produced by recombinant DNA technology and are used as drugs to treat various medical conditions. Recombinant DNA technology involves the use of genetically engineered microorganisms or cells to produce la.....
SynopsisThe valve is one of the key elements of any ventilation system. As epidemic(COVID-19) happens, the demand for such ventilator supplies will increase significantly. The global Medical Expiratory Valve market was valued at US$ million in 2023 and is antici.....
SynopsisCTLA-4 Antibody is a specific antibody designed against CTLA-4 protein (Cytotoxic T-Lymphocyte Antigen 4). The global CTLA-4 Antibody market was valued at US$ 394.6 million in 2023 and is anticipated to reach US$ 894.4 million by 2030, witnessing a CAGR .....
SynopsisAdvanced wound dressings are a category of dressings used to promote wound healing and create an optimal environment for the wound to heal. They are designed to address specific wound characteristics and promote faster healing, reduce pain, prevent infection, .....
SynopsisThe global Esophageal Dilation Balloon market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Esophageal Dilation Balloon is estimat.....
SynopsisThe subcutaneous implantable cardioverter defibrillators (SICD) is an alternative to the transvenous ICD for the prevention of sudden cardiac death (SCD). The global Subcutaneous Implantable Defibrillators market was valued at US$ million in 2023 and is .....
SynopsisThe global Human Hepatitis B Immunoglobulin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. Human hepatitis B immunoglobulin (HBIG) is a blood-derived .....
SynopsisHydroxychloroquine sulfate was listed in the United States in 1955 and used in malaria, rheumatoid arthritis and lupus erythematosus. The variety has been approved in more than 70 countries such as Canada, France, Germany, Australia, China, Japan, etc. H.....
